Literature DB >> 32677847

TCONS_00483150 as a novel diagnostic biomarker of systemic lupus erythematosus.

Gangqiang Guo1,2, Aqiong Chen3, Lele Ye2,4, Huijing Wang5,6, Zhiyuan Chen2, Kejing Yan2, Xinyu Shi2, Baoqing Li7, Qiaoai Lin2, Xiaohan You8, Cizhong Jiang1, Qingfeng Zhang9, Xiaokai Ding8, Xiangyang Xue2, Huidi Zhang8.   

Abstract

Aim: We aimed to identify differentially expressed Long noncoding RNAs (lncRNAs) and explore their functional roles in systemic lupus erythematosus (SLE). Materials & methods: We identified dysregulated lncRNAs and investigated their prognostic values and potential functions using MiRTarget2, catRAPID omics and Bedtools/blast/Pearson analyses.
Results: Among the 143 differentially expressed lncRNAs, TCONS_00483150 could be used to distinguish patients with SLE from healthy controls and those with rheumatoid arthritis and patients with active/stable SLE from healthy controls. TCONS_00483150 was significantly correlated with anti-Rib-P antibody positivity and low C3 levels; TCONS_00483150 dysregulation might contribute to the metabolism of RNA and proteins in SLE patients.
Conclusion: Overall, our findings offer a transcriptome-wide overview of aberrantly expressed lncRNAs in patients with SLE and highlight TCONS_00483150 as a potential novel diagnostic biomarker.

Entities:  

Keywords:  RNA-sequencing; biomarker; long noncoding RNA; systemic lupus erythematosus

Year:  2020        PMID: 32677847     DOI: 10.2217/epi-2019-0265

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  2 in total

Review 1.  LncRNA Expression Profiles in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets.

Authors:  Han Wu; Shuxian Chen; Aifen Li; Kangyuan Shen; Shuting Wang; Sijie Wang; Ping Wu; Wenying Luo; Qingjun Pan
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

2.  MX2: Identification and systematic mechanistic analysis of a novel immune-related biomarker for systemic lupus erythematosus.

Authors:  Xiang-Wen Meng; Zhi-Luo Cheng; Zhi-Yuan Lu; Ya-Nan Tan; Xiao-Yi Jia; Min Zhang
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.